Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 15, 2020 - Issue
Submit an article Journal homepage
265
Views
27
CrossRef citations to date
0
Altmetric
Original Research

The Experience of COPD Patients in Lockdown Due to the COVID-19 Pandemic

Eulogio Pleguezuelos1 Physical Medicine and Rehabilitation Department, Hospital de Mataró, Barcelona, Spain;2 Department of Experimental Science and Healthcare, Faculty of Health Sciences, Universitat Pompeu Fabra, Barcelona, SpainCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0982-2655
ORCID Icon,
Amin Del Carmen1 Physical Medicine and Rehabilitation Department, Hospital de Mataró, Barcelona, SpainORCID Iconhttps://orcid.org/0000-0001-7438-368X
ORCID Icon,
Eva Moreno3 Physical Medicine and Rehabilitation Department, Hospitalet General Hospital, L´Hospitalet de Llobregat, Barcelona, Spain
,
Pilar Ortega4 Pneumology Department, Hospital de Mataró Mataró, Barcelona, Spain
,
Xavier Vila4 Pneumology Department, Hospital de Mataró Mataró, Barcelona, SpainORCID Iconhttps://orcid.org/0000-0003-1744-0689
ORCID Icon,
Laura Ovejero4 Pneumology Department, Hospital de Mataró Mataró, Barcelona, Spain
,
Mateu Serra-Prat5 Research Unit, Consorci Sanitari del Maresme, Barcelona, Spain
,
Elisabet Palomera5 Research Unit, Consorci Sanitari del Maresme, Barcelona, SpainORCID Iconhttps://orcid.org/0000-0002-4384-5746
ORCID Icon,
Manuel Vicente Garnacho-Castaño6 TGRI-AFIRS, Department of Physical Activity and Sports Science, School of Health Sciences, Tecno Campus, Universitat Pompeu Fabra, Barcelona, SpainORCID Iconhttps://orcid.org/0000-0003-3180-4629
ORCID Icon,
Eduardo Loeb7 Pneumology Department, Hospital Universitari Vall d’Hebron, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain
,
Georgina Farago7 Pneumology Department, Hospital Universitari Vall d’Hebron, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, SpainORCID Iconhttps://orcid.org/0000-0002-9982-993X
ORCID Icon &
Marc Miravitlles7 Pneumology Department, Hospital Universitari Vall d’Hebron, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, SpainORCID Iconhttps://orcid.org/0000-0002-9850-9520
ORCID Icon show all
Pages 2621-2627 | Published online: 23 Oct 2020

References

  • HuangC, WangY, LiX, et al. Clinical features of patients infected with 2019 Novel Coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5.31986264
  • Available from: https://www.mscbs.gob.es/en/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_136_COVID-19.pdf. Accessed 616, 2020.
  • ZhouF, YuT, DuR, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-332171076
  • GrasselliG, ZangrilloA, ZanellaA, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574–1581. doi:10.1001/jama.2020.539432250385
  • AlqahtaniJ, OyeladeT, AldhahirA, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One. 2020;15(5):e0233147. doi:10.1371/journal.pone.023314732392262
  • LippiG, HenryBM. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respir Med. 2020;167:105941. doi:10.1016/j.rmed.2020.10594132421537
  • GonçalvesJMF, GolpeR, García-TalaveraI. Chronic obstructive pulmonary disease and SARS-CoV-2 infection. What do we know so far? Arch Bronconeumol. 2020 Jul;56 Suppl 2:5–6. doi:10.1016/j.arbres.2020.04.016
  • BestallJC, PaulEA, GarrodR, GarnhamR, JonesPW, WedzichaJA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586. doi:10.1136/thx.54.7.58110377201
  • JonesPW, HardingG, BerryP, WiklundI, ChenW-H, Kline LeidyN. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34:648–654. doi:10.1183/09031936.0010250919720809
  • BadiaX, RosetM, MontserratS, HerdmanM, SeguraA. La versión española del EUROQoL: descripción y aplicaciones. Med Clin (Barc). 1999;112:79–85.
  • HerreroMJ, BlanchJ, PeriJM, De PabloJ, PintorL, BulbenaA. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry. 2003;25:277–283. doi:10.1016/S0163-8343(03)00043-412850660
  • WedzichaJA, MiravitllesM, HurstJR, et al. Management of COPD exacerbations: an European Respiratory Society/American Thoracic Society (ERS/ATS) guideline. Eur Respir J. 2017;49:1600791. doi:10.1183/13993003.00791-201628298398
  • ChanKPF, MaTF, KwokWC, et al. Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic. Respir Med. 2020;171:106085. doi:10.1016/j.rmed.2020.10608532917356
  • BarreiroE, JiménezC, García de PedroJ, Ramírez PrietoMT. COVID-19 and XXI century pulmonology: challenge or opportunity? Arch Bronconeumol. 2020;56(7):411–412. doi:10.1016/j.arbr.2020.05.00232405135
  • Alcázar-NavarreteB, Molina ParisJ, Martin SanchezFJ. Management and follow up of respiratory patients in the post-COVID-19 era: are we ready yet? Arch Bronconeumol. 2020 Oct;56(10):685–686. doi:10.1016/j.arbr.2020.08.00532405131
  • MiravitllesM, MolinaJ, QuintanoJA, CampuzanoA, PérezJ, RonceroC; DEPREPOC study investigators. Depressive status explains a significant amount of the variance in COPD Assessment Test (CAT) scores. Int J Chron Obstruct Pulmon Dis. 2018;13:823–831. doi:10.2147/COPD.S15479129563782
  • EsquinasC, RamonMA, NuñezA, et al. Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease. Qual Life Res. 2020;29(3):607–617. doi:10.1007/s11136-019-02340-431673922
  • PleguezuelosE, GuiraoL, MorenoE, et al. Safety of rehabilitation program for COPD patients. Arch Bronconeumol. 2018;54(2):111–112. doi:10.1016/j.arbres.2017.06.01228789812
  • PleguezuelosE, Gimeno-SantosE, HernándezC, et al. Recommendations on non-pharmacological treatment in chronic obstructive pulmonary disease from the Spanish COPD guidelines (GesEPOC 2017). Arch Bronconeumol. 2018;54(11):568–575. doi:10.1016/j.arbres.2018.06.00130241689
  • LeungJM, NiikuraM, YangCWT, SinDD. COVID-19 and COPD. Eur Respir J. 2020;56:2002108. doi:10.1183/13993003.02108-202032817205

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.